Norges Bank’s IDEAYA Biosciences IDYA Stock Holding History

Norges Bank’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Buy	+30,589	New	+$936K	﹤0.01%	1567
2026 Q1	–	Sell	-30,589	Closed	-$1.06M	–	663
2025 Q4	$1.06M	Buy	+30,589	New	+$975K	﹤0.01%	1506
2025 Q3	–	Sell	-30,589	Closed	-$643K	–	743
2025 Q2	$643K	Hold	30,589	–	–	﹤0.01%	1598
2025 Q1	$501K	Sell	30,589 -490,221	-94%	-$10.4M	﹤0.01%	1692
2024 Q4	$13.4M	Buy	+520,810	New	+$14.7M	﹤0.01%	1303
2024 Q3	–	Sell	-92,600	Closed	-$3.25M	–	1894
2024 Q2	$3.25M	Buy	+92,600	New	+$3.67M	﹤0.01%	1641
2023 Q4	–	Sell	-12,800	Closed	-$345K	–	1970
2023 Q3	$345K	Sell	12,800 -104,600	-89%	-$2.65M	﹤0.01%	1935
2023 Q2	$2.76M	Hold	117,400	–	–	﹤0.01%	1833
2023 Q1	$1.61M	Sell	117,400 -20,100	-15%	-$335K	﹤0.01%	1948
2022 Q4	$2.5M	Buy	+137,500	New	+$2.31M	﹤0.01%	1938
2019 Q3	–	Sell	-10,000	Closed	-$100K	–	2099
2019 Q2	$100K	Buy	+10,000	New	+$109K	﹤0.01%	2087

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Norges Bank's IDYA Position: Q2 2026 in Review

Norges Bank opened a new position in IDEAYA Biosciences (IDYA) in Q2 2026: 30,589 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #1567 among its holdings. This is a return to the name: Norges Bank previously reported a position in IDYA as recently as Q4 2025.

Norges Bank first reported a position in IDYA in Q2 2019 and has held it in 11 quarters since. The position peaked at $13.4M in Q4 2024. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Norges Bank held 30,589 shares of IDEAYA Biosciences worth $1.14M as of Q2 2026.
IDEAYA Biosciences was a new Norges Bank position in Q2 2026.
IDEAYA Biosciences made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1567 holding.
Norges Bank first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 11 quarters since.
Norges Bank's IDEAYA Biosciences position peaked at $13.4M in Q4 2024.
286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.